Brii biosciences is a biotechnology company developing therapies to address some of the world's most common public health challenges where patients experience high unmet medical needs, limited. Brii biosciences is a biotechnology company developing therapies to improve patients' health by addressing high unmet medical needs with limited treatment options. The company is advancing a.

Brii-179 40ug or placebo were administrated as intramuscular (im) injections every 3 weeks for 7 doses over 18 weeks, in combination with 24 weeks of peg-ifnα treatment. Brii biosciences is a biotechnology company developing therapies to address some of the world's most common public health challenges where patients experience high unmet medical needs, limited.